EVP Schmid sells 22,623 shares of JNJ at $244.20–$244.53 for $5.5M, reducing holdings 45.8%
Timothy Schmid, EVP and WW Chair of MedTech at Johnson & Johnson, executed 2 separate sales on 2026-02-18, selling a combined 22,623 shares for $5,527,505.94 at prices of $244.20 and $244.53. This sale reduced his post-transaction holdings to 26,769 shares from a pre-transaction level of 49,392 shares, representing a net reduction of 45.8% of his prior position. The stock is currently trading at $244.99, near the 52-week high of $244.99, and has posted strong momentum over the trailing 30-day (+12.0%) and 90-day (+20.6%) periods. The company itself shows solid fundamentals with $23,993,000,000 in latest quarterly revenue, $5,152,000,000 in net income, annual growth of 6.0%, and a P/E of 15.59 at a $590.4B market cap. The substantiality of this reduction—nearly half his holdings—merits investor attention, though the transaction occurred proximate to elevated valuation levels without additional context on the underlying rationale.